Actinium Pharmaceuticals
ATNM
ATNM
36 hedge funds and large institutions have $15.9M invested in Actinium Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $18M → $15.9M (-$2.15M)
96% less call options, than puts
Call options by funds: $2K | Put options by funds: $46K
Holders
36
Holding in Top 10
–
Calls
$2K
Puts
$46K
Top Buyers
| 1 | +$516K | |
| 2 | +$457K | |
| 3 | +$389K | |
| 4 |
Morgan Stanley
New York
|
+$212K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111K |
Top Sellers
| 1 | -$1.95M | |
| 2 | -$77K | |
| 3 | -$65.9K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$39.7K |
| 5 |
PP
Patten & Patten
Chattanooga,
Tennessee
|
-$14.8K |